News

Congratulations to Josef Kehrein, Elena Reus, and all collaborators from the BASE-Lipid consortium! They applied a self-regulating microfluidic device, previously established for PEGylated LNPs by our group, on alternative formulations containing poly(2-oxazoline)s. The device autonomously produced particles with high encapsulation efficiency, which were further characterized morphologically through cryogenic transmission electron microscopy and small-angle X-ray scattering. In mice, LNPs decorated with these PEG alternatives exhibited increased biodistribution to the bone marrow and liver, and less to the spleen and pancreas.

Congrats to the contributions of Benedikt Gantert and Tessa Lühmann within the SFB/TRR 225 providing new insights into how the tumor microenvironment shapes cancer cell heterogeneity and metastatic behavior.

Congratulations to Benedikt Gantert! As of July 21, 2026 he successfully defended his thesis entitled „Reporter-conjugated bioinks for the investigation of cellular interactions in biofabrication.“

This project was a cooperation between the Graduate School of Life Sciences and the Chair of Pharmaceutical Technology and Biopharmacy.

Unter diesem Motto stand ein spannender Vormittag, an dem die 24 Kinder der „Schulkindergartengruppe“ des Maria-Ward-Kindergartens einen Einblick in die Arzneimittelherstellung in Apotheken bekamen.

Das Team des Lehrstuhls für Pharmazeutische Technologie der Uni Würzburg erklärte den Kindern die Arzneimittelherstellung in Apotheken und beantwortete Fragen wie z.B.:

- Wo kommen die (Wirk-)Stoffe für die „Medizin“ her?

- Wie kommen diese Stoffe in das Arzneimittel?

- Was muss der Apotheker/die Apothekerin dazu alles können?

As of April 27th, Debora Reinhardt finished her PhD with the defense of her thesis entitled “Development of Diagnostics and Preventive Systems for the Oral Cavity”.

Congratulations!!!

Congrats to Kirstin Meiners and team! Her review highlights strategies for extending half-life and improving clinical performance of protein therapeutics!

Congratulations to Elena Reus! As of April 23, 2026 she successfully defended her thesis entitled „Self-regulating process for the production and characterization of lipid nanoparticles“. All the best for your future.

Congrats to Fiona, Simon, Christoph and the whole team for this comprehensive review on local carbon monoxide delivery — from CO-releasing molecules to advanced drug delivery systems like patches, capsules, and nanocarriers! This work charts a clear path from the "silent killer" to a targeted therapeutic gas with exciting clinical potential.

Congratulations to Alena Wolkersdorfer! As of February 24, 2026 she successfully defended her thesis entitled „Design and Pharmacokinetic Optimization of Enzymatic and Growth Factor-based Protein Therapeutics“.

Die Forschung der Pharmazeutischen Technologie in Würzburg ist sprichwörtlich „in aller Munde“.

Mittlerweile hat sich die Entwicklung unseres „Grippeviren-Kaugummis“ soweit herumgesprochen,

dass sie sogar in Quiz-Shows des Deutschen Fernsehens (täglich 18.00-18.50 Uhr ARD: „Wer weiß denn sowas?“

mit Kai Pflaume) als außergewöhnlich dargestellt wird!!

Congrats to Martin and Eduardo for developing peptides for reversible binding to sugar-rich structures (glycans) in cell-derived extracellular matrix models using boronic acid chemistry!

This approach offers exciting potential for peptide drug depots from injectable solutions.

It might sound like something straight out of science fiction, but it could soon become part of everyday hospital care: tiny microrobots filled with active agents are injected into the bloodstream, guiding medications with incredible accuracy. A collaborative international research team - including scientists from Prof. Tessa Lühmann’s group at the Institute of Pharmacy and Food Chemistry, University of Wuerzburg - has just made a significant breakthrough in this exciting field.

Congratulations to Martina Raschig and the whole team! They synthesized sensors that respond to influenza infections with taste generation by using the tongue as an always-available detector. Their research represents a major step towards higher accessibility and cost-effectiveness, including the potential to first-line stratify millions of healthy individuals from flu patients.

Congratulations to Elena Reus and her team, who, together with colleagues from Aachen, have made a valuable contribution to a deeper understanding of the production of lipid nanoparticles. They combined simulated fluid flow dynamics and machine learning with high-throughput methods to accelerate formulation science.

As of October 27th, Christoph Ehrbar-Spangardt successfully defended his thesis entitled “Proof of Concept and Feasibility of Active Autoinjector Systems". Well done!